Even if efforts to develop a vaccine are successful (New Scientist, 26 March, p 10), it could take many months to produce the billions of doses needed in the event of a pandemic. By then it might be too late. So in the meantime, the World Health Organization is stepping up its efforts to acquire a massive stockpile of Tamiflu (oseltamivir), which it hopes will at least slow any emerging flu pandemic.
Recent cases of H5N1 in northern Vietnam have caused concern because of signs that the virus is changing. It has become less lethal and is occurring in larger clusters than past cases. Last month studies also revealed that the virus is diverging genetically.
Tamiflu can save lives if it is given early, no more than two days after symptoms first appear. But last month the WHO reported that a patient in Vietnam had a strain of H5N1 resistant to Tamiflu. So could the drug become useless before the pandemic even begins?
This article continues in www.newscientist.com
Copyright ? The New Scientist
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Nordqvist, Christian. "Can Tamiflu save us from bird flu?." Medical News Today. MediLexicon, Intl., 1 Jun. 2005. Web.
26 Jun. 2017. <http://www.medicalnewstoday.com/releases/25455.php>
Nordqvist, C. (2005, June 1). "Can Tamiflu save us from bird flu?." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.